Learn more about whether BioMarin Pharmaceutical Inc. or Avidity Biosciences, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.
Data demonstrates sustained clinical improvements in pain, stiffness and function for up to 156 weeks following a single administration of ...
Detailed price information for Pacira Pharm Inc (PCRX-Q) from The Globe and Mail including charting and trades.
Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Alligator ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Satellos Bioscience ( (TSE:MSCL)) has ...
GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Taylor Soper on Oct 8, 2025 at 7:41 ...
Spruce Biosciences shares reached a 52-week high after a drug update and favorable comments on X by Martin Shkreli. Spruce said the Food and Drug Administration granted Breakthrough Therapy ...
Shares of Spruce Biosciences, Inc. (NASDAQ:SPRB) are surging Monday after the biotech company shared an important regulatory update about one of its therapy treatments. What To Know: Spruce ...
WASHINGTON — Cubic Defense is pursuing military customers for its flat-panel satellite communications terminal designed to operate across multiple orbits and networks. The San Diego-based military ...
Niagen Bioscience's Pharmaceutical-Grade Niagen™ IV and Injections Now Available at over 50 iCRYO Clinics and More than 900 Total Clinics Nationwide Niagen IV and injections perfectly align ...
Colossal Biosciences, in Dallas, Texas, describes itself as the world’s first de-extinction company. It aims to revive lost species using CRISPR gene-editing technology, including the mammoth ...